IRIC - Institute for Research in Immunology and Cancer

Published on October 26, 2016

The Institute for Research in Immunology and Cancer — Commercialization of Research (IRICoR) of the Université de Montréal announces its nomination as finalist of the Prix Innovation 2016 (French only) of the Association pour le développement de la recherche et de l’innovation du Québec (ADRIQ), in the Life Sciences category.
This Prix Innovation | Life Science aims to highlight the performance of a company, group, organization and (or) an individual who significantly contributes to the development of biotechnology, life sciences and technologies health in Quebec.

Ms Nadine Beauger, CEO of IRICoR and Anne Marinier, principal investigator and director of medicinal chemistry at the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal, participated Wednesday, October 19th, 2016, to the awarding of certificates by Mr. Pascal Monette, CEO of ADRIQ.

The winners of the Prix Innovation will be announced before some 400 decision-makers of the ecosystem of research and innovation in Quebec, at the 26th edition of the Gala des Prix Innovation ADRIQ. This Gala, recognized as the most prestigious event of the innovation environment in Quebec, will discuss “Relief” and will be held Thursday, November 24, 2016, in Montreal.